VERANDA-SSc: study design of a phase III, randomised, placebo-controlled trial evaluating the efficacy and safety of oral nerandomilast treatment in systemic sclerosis

By afschroeder • November 7, 2026

Hoffmann-Vold AM, Distler O, Allanore Y, Del Galdo F, Denton CP, Kuwana M, Khanna D, McMahan ZH, Volkmann ER, Li H, Dumistracel M, Gahlemann M, Stowasser S, Assassi S. VERANDA-SSc: study design of a phase III, randomised, placebo-controlled trial evaluating the efficacy and safety of oral nerandomilast treatment in systemic sclerosis. J Scleroderma Relat Disord. 2026 Nov 2;11(2):e000052. doi: 10.1136/jsrd-2026-000052. PMID: 42991098; PMCID: PMC13735304.

Tags: Autoimmune Diseases, Publications, Rheumatology, Scleroderma, Systemic, Therapeutics

Jackhammer Esophagus Presenting as Chest Discomfort and Dyspnea in a Patient With Undifferentiated Inflammatory Arthritis and a Positive Scl-70 Antibody Test

Perini Villanueva G, Kokaly A, Sunku N, Chung CW. Jackhammer Esophagus Presenting as Chest Discomfort and Dyspnea in a Patient With Undifferentiated Inflammatory Arthritis and[...]

Association Between Colchicine Use and Clinical Outcomes Post Cardiac Surgery: A Meta-analysis of Randomized Controlled Trials

Jaiswal V, Hanif M, Raja HAA, Khadka S, Deb N, Mashkoor Y, Ahmed A, Rajak K, Jaiswal AK, Gupta M, Hirji S, Fonarow GC, Qamar[...]

A Multicenter Randomized Controlled Trial of a Digital Health Intervention for Medication Optimization in Heart Failure: The ENGAGE-HF Trial Outcomes

Dorsch MP, Gilotra NA, Spaulding EM, Martin SS, Zhao H, Wilson GA, Poddar M, Verma A, Schmiedmayer P, Kraft P, Rodriguez F, Azizi Z, Hwang[...]